Define and distinguish incomplete penetrance and variable expressivity.
To analyze:
The differences and definitions for the given terms – Incomplete penetrance and Variable expressivity.
Introduction:
The phenotypic variation seen in the population is due the genotypic difference that results in that phenotype. If a particular genotype produces the expected phenotype, it said to be complete penetrance. On the other hand, if a genotype does not produce the expected phenotype, but rather results in a variable phenotype, the reason behind this is gene-environmental interactions between the alleles of other genes in the genome.
Explanation of Solution
Explanation:
Penetrance- If a phenotype is accordant with the genotype, the organism is said to be “Penetrant” for the trait whereas if the phenotype is inconsistent with the genotype, it said to be “Non-penetrant.” When the traits for a genotype result in the estimated phenotype, it is called “Fully penetrant” while if the organism has the effective gene but still fails to show the expected phenotype, it is called an incomplete penetrance. The highly penetrated alleles are studied by clinicians and geneticist. The importance of studying the penetrance benefits in identifying the individuals who are prone to a particular disease.
Expressivity- Expressivity is the extent to which an individual shows a phenotype or a trait or mutation. The variable expressivity refers to the phenotypic expression to a different degree with the same genotype.
a. Incomplete penetrance- If the organism has the effective gene still it fails to show the expected phenotype, it is called incomplete penetrance.
b. Variable expressivity- The degree of phenotypic expression varies in different individual with the same genotype.
Sr No. | Incomplete penetrance | Variable expressivity |
1. | Individual do not express the phenotype; however they have the allele. | Symptoms contrast in intensity in different individuals. |
2. | Example- Polydactyly. | Example- Waardenburg syndrome. |
Thus it is concluded that incomplete penetrance is a condition in which the organism has the effective gene still it fails to show the expected phenotype. Variable expressivity is the degree of phenotypic expression that varies in different individual with the same genotype.
Want to see more full solutions like this?
Chapter 4 Solutions
Genetic Analysis: An Integrated Approach (3rd Edition)
Additional Science Textbook Solutions
Microbiology with Diseases by Body System (5th Edition)
Chemistry: An Introduction to General, Organic, and Biological Chemistry (13th Edition)
Applications and Investigations in Earth Science (9th Edition)
Concepts of Genetics (12th Edition)
Campbell Biology in Focus (2nd Edition)
Human Anatomy & Physiology (2nd Edition)
- questions about GMOs (genetically modified organisms): (1) Explain the agrobacterium-based method for GMO development. (2) What are the criteria that determine the safety of GMOs? (3) Explain how to differentiate GMO from non-GMO productarrow_forwardExplain the principle of lateral flow assay (LFA) used as a point-of-care testing (POCT) technology.arrow_forwardThe following is the partial sequence of a bacterial gene ORF: 5’ --------------------CGGAATTCCCGGGGATCC------------------------3’ (The remaining sequence of the gene ORF never affects the cloning of this gene. The multiple cloning sites of the plasmid vector can be cleaved by 8 restriction endonucleases that are listed in the table. 5’- and 3’-end sequences of the bacterial gene ORF are 5’ ATGGAGT TATCCAGGTGCCT--- and 3’AATATGGAGTTATCCAGGTGCCT---, respectively. After choosing the appropriate restriction endonuclease(s) for directional cloning using the table below, determine the sequences of two 20-mer primers used for the PCR amplification of the gene ORF.arrow_forward
- Explain the terms: SNP and precision medicinearrow_forwardExplain the terms: innate immunity, adaptive immunity, major histocompatibility complex (MHC), and CAR-T.arrow_forwardFor what purposes of preclinical and clinical trial phases I, II, and III are required in steps to marketing a therapeutic pharmaceutical?arrow_forward
- The following is the partial sequence of a bacterial gene ORF: 5’ --------------------CGGAATTCCCGGGGATCC------------------------3’ (The remaining sequence of the gene ORF never affects the cloning of this gene. The multiple cloning sites of the plasmid vector can be cleaved by 8 restriction endonucleases that are listed in the tableCompare the cloning efficiencies: SmaI vs. EcoRI.arrow_forwardExplain the term, induced pluripotent stem (iPS) cells.arrow_forwardThe 2-dimensional electrophoresis (2-DE) and chromatography are the key technologies useful for proteomics. (1) Explain the protein separation principles of 2-DE. (2) Explain the separation principles of the following four chromatographic protein purifications: ion exchange, hydrophobic interaction, affinity, and gel filtration.arrow_forward
- Human Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage LearningHuman Biology (MindTap Course List)BiologyISBN:9781305112100Author:Cecie Starr, Beverly McMillanPublisher:Cengage Learning